Prevalence of COVID-19 in prison population: a meta-analysis of 35 studies.
Int J Prison Health (2024)
; 2024 09 17.
Article
em En
| MEDLINE
| ID: mdl-39267228
ABSTRACT
PURPOSE:
COVID-19 is an infectious disease caused by the SARS-CoV-2 virus. Considering the restricted and enclosed nature of prisons and closed environments and the prolonged and close contact between individuals, COVID-19 is more likely to have a higher incidence in these settings. This study aims to assess the prevalence of COVID-19 among prisoners. DESIGN/METHODOLOGY/APPROACH:
Papers published in English from 2019 to July 7, 2023, were identified using relevant keywords such as prevalence, COVID-19 and prisoner in the following databases PubMed/MEDLINE, Scopus and Google Scholar. For the meta-analysis of the prevalence, Cochrane's Q statistics were calculated. A random effect model was used due to the heterogeneity in COVID-19 prevalence across included studies in the meta-analysis. All analyses were performed in STATA-13.FINDINGS:
The pooled data presented a COVID-19 prevalence of 20% [95%CI 0.13, 0.26] and 24% [95%CI 0.07, 0.41], respectively, in studies that used PCR and antibody tests. Furthermore, two study designs, cross-sectional and cohort, were used. The results of the meta-analysis showed studies with cross-sectional and cohort designs reported 20% [95%CI 0.11, 0.29] and 25% [95%CI 0.13, 0.38], respectively. ORIGINALITY/VALUE Through more meticulous planning, it is feasible to reduce the number of individuals in prison cells, thereby preventing the further spread of COVID-19.Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Prisões
/
Prisioneiros
/
COVID-19
Limite:
Humans
Idioma:
En
Revista:
Int J Prison Health (2024)
Ano de publicação:
2024
Tipo de documento:
Article
País de afiliação:
Irã
País de publicação:
Reino Unido